Indian pharma stocks gain after US resumes funding HIV treatments

Strides Pharma Science

30/01/2025 09:43

** Shares of Indian Pharma companies which make drugs for
HIV rise between 2% to 13%
    ** U.S. decides to resume funding HIV treatment after
pausing the foreign aid on Jan. 26
    ** Strides Pharma  SRID.NS  up 13%, Laurus Labs  LAUL.NS 
rise 8%, Aurobindo Pharma  ARBN.NS  rise 3% and Cipla  CIPL.NS 
up 2%
    ** Strides, which reported 77% rise in Q3 profit earlier in
the day, is top gainer on the pharma index  .NIPHARM  which is
up 1%
    ** Since Jan. 26, LAUL down 10% and SRID fell 5% as of last
close, while SRID was largely flat and Cipla was up 1%

 (Reporting by Nishit Navin)
 ((nishit.navin@thomsonreuters.com;))